Assessment of carotid intima-media thickness in patients with type 2 diabetes mellitus and arterial hypertension
https://doi.org/10.14341/DM2014141-46
Abstract
Atherosclerosis is one of the most important complications of type 2 diabetes mellitus (T2DM). In the present study, we aimed to assess the carotid intima-media thickness in type 2 diabetes patients with the arterial hypertension (AH) comorbidity.
Materials and Methods.
96 patients with T2DM and AH (30M/66F, aged 53.4?5.4 years, duration of diabetes 7.7?7.5 years) and 30 hypertensive patients without diabetes (12M/18F, aged 53.1?6.0 years) were enrolled in this study. Stiffness indices for right and left common carotid arteries were assessed with noninvasive ultrasound method in both groups.
Results.
Difference in the intima-media thickness was statistically significant between diabetic and euglycemic patients (1.26?0.17 mm vs. 1.10?0.14 mm, respectively; p<0.01). Data from patients with diabetes duration less than 1 year was not significantly different from euglycemic controls (1.20?0.20 mm vs. 1.10?0.14 mm, respectively; p>0.05), in contrast with their counterparts with longer experience of T2DM (1.27?0.17 mm vs. 1.10?0.14 mm; p<0.05). In patients with AH and T2DM, intima-media thickness positively correlated with systolic blood pressure (r=0.521, p<0.01), duration of diabetes (r=0.203, p<0.05), fasting plasma glucose (r=0.215, p<0.05) and plasma HDL (r=-0.288, p<0.05). In euglycemic patients with AH we observed a correlation between the intima-media thickness and systolic blood pressure (r=0.284, p<0.05).
Conclusion.
Our data indicate that patients with AH and T2DM exhibit more profound alterations in the intima-media compared to their hypertensive but euglycemic counterparts. The increase in intima-media thickness in DM patients depends not only on the level of systolic blood pressure, but also on the duration of diabetes, on fasting plasma glucose and on plasma levels of HDL.
About the Authors
Irina Arkad'evna Bondar'Russian Federation
MD, PhD, Professor, Head of the Endocrinology department
Alexander Aristarkhovich Demin
Russian Federation
MD, PhD, Professor, Head of the Hospital Therapy and Clinical Pharmacology Department
Olesya Yur'evna Shabel'nikova
Russian Federation
MD, PhD, Head of the regional diabetes center
Viktoriya Alexandrovna Onyanova
Russian Federation
MD, PhD, Ultrasound and cardiorespiratory diagnostic department
References
1. Sasaki T, Watanabe M, Nagai Y, Hoshi T, Takasawa M, Nukata M, et al. Association of plasma homocysteine concentration with atherosclerotic carotid plaques and lacunar infarction. Stroke. 2002;33(6):1493-1496. Available from: http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=12052980 PubMed PMID: 12052980. doi: 10.1161/01.STR.0000016463.01398.D0.
2. Hulthe J, Wikstrand J, Emanuelsson H, Wiklund O, de Feyter PJ, Wendelhag I. Atherosclerotic changes in the carotid artery bulb as measured by B-mode ultrasound are associated with the extent of coronary atherosclerosis. Stroke 1997;28(6):1189-1194. Available from: http://stroke.ahajournals.org/cgi/pmidlookup?view=long&pmid=9183349 PubMed PMID: 9183349. doi: 10.1161/01.STR.28.6.1189.
3. Djaberi R, Schuijf JD, Jukema JW, Rabelink TJ, Stokkel MP, Smit JW, et al. Increased carotid intima-media thickness as a predictor of the presence and extent of abnormal myocardial perfusion in type 2 diabetes. Diabetes Care 2009;33(2):372-374. Available from: http://europepmc.org/abstract/MED/19918012 PubMed PMID: 19918012. doi: 10.2337/dc09-1301.
4. Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, et al. Carotid Wall Thickness is Predictive of Incident Clinical Stroke: The Atherosclerosis Risk in Communities (ARIC) Study. American Journal of Epidemiology 2000;151(5):478-487. Available from: http://aje.oxfordjournals.org/cgi/doi/10.1093/oxfordjournals.aje.a010233 PubMed PMID: 10707916. doi: 10.1093/oxfordjournals.aje.a010233.
5. Dijk JM, van der Graaf Y, Bots ML, Grobbee DE, Algra A. Carotid intima-media thickness and the risk of new vascular events in patients with manifest atherosclerotic disease: the SMART study. European Heart Journal 2006 июля;27(16):1971-1978. Available from: http://eurheartj.oxfordjournals.org/cgi/doi/10.1093/eurheartj/ehl136 PubMed PMID: 16835264. doi: 10.1093/eurheartj/ehl136.
6. Murakami S, Otsuka K, Hotta N, Yamanaka G, Kubo Y, Matsuoka O, et al. Common carotid intima-media thickness is predictive of all-cause and cardiovascular mortality in elderly community-dwelling people: Longitudinal Investigation for the Longevity and Aging in Hokkaido County (LILAC) study. Biomed Pharmacother 2005;59 Suppl 1. Available from: http://europepmc.org/abstract/MED/16275507 PubMed PMID: 16275507.
7. Spijkerman AMW, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CDA, Bouter LM, et al. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002;25(10):1784-1789. Available from: http://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+hsdb:@term+@rn+57-88-5 PubMed PMID: 12351478.
8. Yoshida M, Mita T, Yamamoto R, Shimizu T, Ikeda F, Ohmura C, et al. Combination of the Framingham risk score and carotid intima-media thickness improves the prediction of cardiovascular events in patients with type 2 diabetes.. Diabetes Care 2011;35(1):178-180. Available from: http://europepmc.org/abstract/MED/22028278 PubMed PMID: 22028278. doi: 10.2337/dc11-1333.
9. Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J, Hori M. Intima-media thickness: a new tool for diagnosis and treatment of cardiovascular risk. Journal of Hypertension. 2002; 20(2).159–169.
10. Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, et al. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care 2000;23(9):1310-1315. Available from: http://dx.doi.org/10.2337/diacare.23.9.1310 PubMed PMID: 10977024. doi: 10.2337/diacare.23.9.1310.
11. Intensive Diabetes Therapy and Carotid Intima–Media Thickness in Type 1 Diabetes Mellitus. N Engl J Med 2003;348(23):2294-2303. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa022314 doi: 10.1056/NEJMoa022314.
12. Marinchev A, Kamenova P. Relationship of insulin sensitivity with carotid intima media thickness in patients with type 2 diabetes mellitus. European Congress of Endocrinology. Endocrine Abstracts 2008;16:209.
13. Drechsler D, Kornacewicz Janh Z . Assessment of carotid arteries and Pulse Wave Velocity in patients with three vessel coronary disease. Kardiologia Polska 2002;(57):193-197.
14. Bluth EI, Stavros AT, Marich KW, Wetzner SM, Aufrichtig D, Baker JD. Carotid duplex sonography: a multicenter recommendation for standardized imaging and Doppler criteria. RadioGraphics 1988;8(3):487-506. Available from: http://pubs.rsna.org/doi/abs/10.1148/radiographics.8.3.3289100 doi: 10.1148/radiographics.8.3.3289100.
15. Lehoux S, Castier Y, Tedgui A. Molecular mechanisms of the vascular responses to haemodynamic forces. J Intern Med 2006;259(4):381-392. Available from: http://dx.doi.org/10.1111/j.1365 PubMed PMID: 16594906. doi: 10.1111/j.1365-2796.2006.01624.x.
16. Wang H, Yu M, Ochani M, Amella CA, Tanovic M, Susarla S, et al. Nicotinic acetylcholine receptor [alpha]7 subunit is an essential regulator of inflammation. Nature 2003;421(6921):384-388. Available from: http://www.nature.com/doifinder/10.1038/nature01339 doi: 10.1038/nature01339.
17. Yokoyama H, Katakami N, Yamasaki Y. Recent Advances of Intervention to Inhibit Progression of Carotid Intima-Media Thickness in Patients With Type 2 Diabetes Mellitus. Stroke 2006;37(9):2420-2427. Available from: http://dx.doi.org/10.1161/01.STR.0000236632.58323.cd PubMed PMID: 16888250. doi: 10.1161/01.STR.0000236632.58323.cd.
18. Chiasson JL, Josse RG, Gomis R, Hanefeld M, Karasik A, Laakso M. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. The Lancet 2002;359(9323):2072-2077. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673602089055 doi: 10.1016/S0140-6736(02)08905-5.
19. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction. N Engl J Med 1998 июля;339(4):229-234. Available from: http://www.nejm.org/doi/abs/10.1056/NEJM199807233390404 PubMed PMID: 9673301. doi: 10.1056/NEJM199807233390404.
20. Kastelein JJP, van Leuven SI, Burgess L, Evans GW, Kuivenhoven JA, Barter PJ, et al. Effect of Torcetrapib on Carotid Atherosclerosis in Familial Hypercholesterolemia. N Engl J Med 2007;356(16):1620-1630. Available from: http://www.nejm.org/doi/abs/10.1056/NEJMoa071359 PubMed PMID: 17387131. doi: 10.1056/NEJMoa071359.
21. Bots ML, Visseren FL, Evans GW, Riley WA, Revkin JH, Tegeler CH, et al. Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial. The Lancet 2007;370(9582):153-160. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673607610885 PubMed PMID: 17630038. doi: 10.1016/S0140-6736(07)61088-5.
22. Kasami R, Kaneto H, Katakami N, Sumitsuji S, Yamasaki K, Kuroda T, et al. Relationship Between Carotid Intima-Media Thickness and the Presence and Extent of Coronary Stenosis in Type 2 Diabetic Patients With Carotid Atherosclerosis but Without History of Coronary Artery Disease. Diabetes Care 2011;34(2):468-470. Available from: http://care.diabetesjournals.org/cgi/doi/10.2337/dc10-1222 PubMed PMID: 21270201. doi: 10.2337/dc10-1222.
Supplementary files
Review
For citations:
Bondar' I.A., Demin A.A., Shabel'nikova O.Yu., Onyanova V.A. Assessment of carotid intima-media thickness in patients with type 2 diabetes mellitus and arterial hypertension. Diabetes mellitus. 2014;17(1):41-46. (In Russ.) https://doi.org/10.14341/DM2014141-46

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).